Overview on effectiveness of erenumab, fremanezumab, and galcanezumab in reducing medication overuse headache in chronic migraine patients.

Authors
Category Primary study
JournalNeurological Sciences
Year 2022
This article has no abstract
Epistemonikos ID: 3969e111c024acb38c352daff7dac34845dc8b3b
First added on: Apr 07, 2025